Is a complete KYMR research report available?

No complete published report is available for Kymera Therapeutics, Inc. (KYMR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Kymera Therapeutics, Inc. (KYMR)

NASDAQ: KYMR · USD

$106

-3.88 (-3.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first KYMR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	8.7B
Revenue (ttm)	51.5M
Net income (ttm)	-315M
EPS (ttm)	-$3.55
Shares out	82.3M
Volume	679,738
Beta	1.96
Price target	$128	+20.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 51.5M
Net income (ttm): -315M
EPS (ttm): -$3.55
Market cap: 8.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All KYMR indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001815442
Company name	Kymera Therapeutics, Inc.
Country	United States
Country code	US
Cusip	501575104
Employees	253
Employees Change	45%
Employees Change Percent	21.63
Enterprise value	$7.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-08-21
Isin	US5015751044
Last refreshed	2026-07-29
Market cap	$8.7B
Market cap category	Mid-Cap
Price	$106
Price currency	USD
Rev Per Employee	203,462.45x
Sector	Healthcare
Sector PE	45.6
Sector PE Fwd	24.3
Sic	2836
Symbol	KYMR
Website	https://www.kymeratx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.61%
EV Sales Forward	116.12x
EV/Sales	141.14x
FCF yield	-2.79%
P/B ratio	5.67x
P/S ratio	169.6x
PS Forward	139.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-697.67%
EBITDA Margin	-681.58%
Gross Profit	$-283M
Net Income	$-315M
Net Income Growth Years	0%
Pretax Margin	-611.94%
Profit Per Employee	$-1.2M
ROA	-17.16
Roa5y	-16.45
ROCE	-22.36
ROE	-27.09
Roe5y	-30.99
ROIC	-17.82

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	131.98%
Cagr3y	68.56%
Cagr5y	12.8%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-12.58x
Revenue Growth Q	55.5x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	3.32x
Revenue Growth5 Y	0.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.04
Assets	$1.7B
Cash	$650.9M
Current Assets	$677.4M
Current Liabilities	$62.6M
Debt	$80.5M
Debt Equity	$0.05
Equity	$1.5B
Interest Coverage	-1,000.4
Liabilities	$129.4M
Long Term Assets	$991.6M
Long Term Liabilities	$66.7M
Net Cash	$1.5B
Net Cash By Market Cap	$16.78
Net Cash Growth	112.61%
Net Debt Equity	$-0.95
Tangible Book Value	$1.5B
Tangible Book Value Per Share	$18.73
WACC	14.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.81
Net Working Capital	$-22.4M
Quick ratio	10.39
Working Capital	$614.8M
Working Capital Turnover	$0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.8%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	131.84%
200-day SMA	81.46
3Y total return	379.06%
50-day SMA	96.55
50-day SMA vs 200-day SMA	50over200
5Y total return	82.59%
All Time High	130.1
All Time High Change	-18.37%
All Time High Date	2026-06-25
All Time Low	9.6
All Time Low Change	1,005.83%
All Time Low Date	2023-11-02
ATR	5.67
Beta	1.96
Beta1y	0.81
Beta2y	1.84
Ch YTD	36.44
High	110.4
High52	130.1
High52 Date	2026-06-25
High52ch	-18.37%
Low	105.5
Low52	36.65
Low52 Date	2025-08-11
Low52ch	189.66%
Ma50ch	9.95%
Premarket Change Percent	-0.24
Premarket Price	$110
Premarket Volume	7,505
Price vs 200-day SMA	30.32%
RSI	48.12
RSI Monthly	70.34
RSI Weekly	61.84
Sharpe ratio	1.54x
Sortino ratio	3.26
Total Return	-14.8%
Tr YTD	36.44
Tr1m	-1.81%
Tr1w	-6.36%
Tr3m	22.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	23
Analyst Count Top	16
Analyst Price Target Top	$126
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.72
Earnings Revenue Estimate	32,558,000x
Earnings Revenue Estimate Growth	183.71x
Operating Income	$-355.3M
Operating margin	-690.2
Price target	$128
Price Target Change	$20.12
Price Target Change Top	$18.82

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	65,161,659%
Float Percent	79.22%
Net Borrowing	-1,642,000
Shares Insiders	1.16%
Shares Institutions	94.41%
Shares Out	82,257,588
Shares Qo Q	8.47%
Shares Yo Y	14.8%
Short Float	15.19%
Short Ratio	7.75
Short Shares	12.04

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-305.7M
Adjusted OCF	-304,259,000
Average Volume	661,209.4x
Bv Per Share	18.73
CAPEX	$-1.4M
Ch1m	-1.81
Ch1w	-6.36
Ch1y	131.8
Ch3m	22.47
Ch3y	379.1
Ch5y	82.59
Ch6m	47.14
Change	-3.53%
Change From Open	-2.41
Close	110.1
Days Gap	-1.15
Depreciation Amortization	6,687,000
Dollar Volume	72,160,986.1
Earnings Date	2026-08-05
Earnings Time	bmo
EBIT	$-359.1M
EBITDA	$-350.8M
EPS	$-3.55
F Score	2
FCF	$-244M
FCF EV Yield	-3.36x
FCF Per Share	$-2.97
Financing CF	1,009,224,000
Fiscal Year End	December
Founded	2,015
Investing CF	-712,516,000
Ipr	430.8
Iprfo	203.3
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	86.42
Ma150ch	22.85%
Ma20	113.4
Ma20ch	-6.35%
Net CF	54,127,000
Next Earnings Date	2026-08-05
Open	108.8
Optionable	Yes
Position In Range	14.46
Post Close	106.2
Postmarket Change Percent	1.4
Postmarket Price	$108
Ppne	83,353,000
Pre Close	110.1
Price Date	2026-07-28
Ptbv Ratio	5.67
Relative Volume	1.03x
Revenue	51,476,000x
SBC By Revenue	119.82x
Share Based Comp	61,678,000
Tr6m	47.14%
Us State	Massachusetts
Volume	679,738
Z Score	18.29

Kymera Therapeutics, Inc. (KYMR)

Coverage state: Market snapshot only — no published research

Generate the first KYMR analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · KYMR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KYMR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on KYMR

Frequently asked questions